1CM
NPTN

1492 Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

1492 Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,500
Closed -$178K – 110
2016
Q4 		$178K Buy
+16,500
New +$220K 0.14% 98

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

1492 Capital Management's NPTN Position: Q1 2017 in Review

1492 Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2017, closing a stake of 52,814 shares — an estimated $571K sold.

1492 Capital Management first reported a position in NPTN in Q4 2015 and held it in 5 quarters. The position peaked at $1.63M in Q1 2016. 126 funds tracked by Wall St. Rank hold NPTN as of Q1 2017.

  • 1492 Capital Management reported no remaining NEOPHOTONICS CORP position as of Q1 2017 after selling out during the quarter.
  • 1492 Capital Management sold 52,814 NEOPHOTONICS CORP shares in Q1 2017, an estimated $571K.
  • 1492 Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2015 and held it in 5 quarters.
  • 1492 Capital Management's NEOPHOTONICS CORP position peaked at $1.63M in Q1 2016.
  • 126 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2017.

Based on 1492 Capital Management's 13F filing for Q1 2017, filed 15 May 2017.